Topics
CNS Tumors | Outcomes | Overview
Home > Publications > Topics > CNS Tumors > Outcomes > Overview
TRK fusion-driven primary CNS tumors
Lamoureux AA, Fisher MJ, Lemelle L, Pfaff E, Amir-Yazdani P, Kramm
C, De Wilde B, Kazanowska B, Hutter C, Pfister SM, Sturm D, Jones
DTW, Orbach D, Pierron G, Raskin S, Drilon A, Diamond EL, Harada
G, Zapotocky M, Zamecnik J, Krskova L, Ellezam B, Weil AG, Venne
D, Barritault M, Leblond P, Coltin H, Hammad R, Tabori U, Hawkins
C, Hansford JR, Meyran D, Erker C, McFadden K, Sato M, Gottardo
NG, Dholaria H, Nørøxe DS, Goto H, Ziegler DS, Lin
FY, Parsons DW, Lindsay H, Wong TT, Liu YL, Wu KS, Franson AT,
Hwang E, Aguilar-Bonilla A, Cheng S, Cacciotti C, Massimino M,
Schiavello E, Wood P, Hoffman LM, Cappellano A, Lassaletta A, Van
Damme A, Llort A, Gerber NU, Spalato Ceruso M, Bendel AE, Skrypek
M, Hamideh D, Mushtaq N, Walter A, Jabado N, Alsahlawi A, Farmer
JP, Coleman C, Mueller S, Mazewski C, Aguilera D, Robison NJ,
O'Halloran K, Abbou S, Berlanga P, Geoerger B, Øra I,
Moertel CL, Razis ED, Vernadou A, Ducray F, Bronnimann C, Seizeur
R, Clarke M, Resnick AC, Alves M, Jones C, Doz F, Laetsch TW,
Perreault S.
Clinical characteristics
and outcome of central nervous system
tumors harboring NTRK gene fusions.
Clin
Cancer Res. 2024 Dec 3. doi:
10.1158/1078-0432.CCR-24-0581. PMID:
39625867. Observational study. ˍ